PDS Biotechnology Corporation (PDSB)

NASDAQ: PDSB · IEX Real-Time Price · USD

2.950

-0.080 (-2.64%)

At close: Jul 2, 2024, 4:00 PM

3.000

+0.050 (1.69%)

After-hours: Jul 2, 2024, 6:21 PM EDT

PDS Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2014
Market Capitalization	108	155	376	230	48	15	Upgrade
Market Cap Growth	-23.13%	-58.92%	63.38%	383.47%	211.09%	52.28%	Upgrade
Enterprise Value	66	122	326	166	19	3	Upgrade
PE Ratio	-	-3.60	-9.21	-13.61	-3.21	-2.19	Upgrade
PB Ratio	2.91	5.92	8.55	3.64	1.76	1.31	Upgrade
P/FCF Ratio	-4.78	-4.60	-14.64	-18.45	-3.62	-0.86	Upgrade
P/OCF Ratio	-4.78	-4.60	-14.64	-18.45	-3.62	-0.85	Upgrade
EV/EBITDA Ratio	-2.36	-2.84	-7.87	-7.81	-1.32	-0.43	Upgrade
EV/EBIT Ratio	-2.35	-2.83	-7.82	-7.72	-1.31	-0.43	Upgrade
EV/FCF Ratio	-3.38	-3.62	-12.68	-13.26	-1.48	-0.18	Upgrade
Debt / Equity Ratio	0.65	0.91	0.53	0.01	0.02	-	Upgrade
Debt / EBITDA Ratio	-0.55	-0.56	-0.57	-0.02	-0.04	-	Upgrade
Debt / FCF Ratio	-0.79	-0.71	-0.91	-0.04	-0.05	-	Upgrade
Quick Ratio	4.42	4.15	7.52	17.37	8.82	4.35	Upgrade
Current Ratio	4.56	4.33	7.79	17.80	9.28	5.18	Upgrade
Interest Coverage	-27.82	-33.04	-109.28	-	-	-218.91	Upgrade
Return on Equity (ROE)	-146.00%	-138.40%	-82.40%	-29.60%	-62.50%	-38.70%	Upgrade
Return on Assets (ROA)	-70.40%	-69.00%	-60.80%	-27.70%	-54.30%	-30.90%	Upgrade
Return on Capital (ROIC)	-71.33%	-86.12%	-61.76%	-33.66%	-53.72%	-179.82%	Upgrade
Earnings Yield	-40.56%	-27.78%	-10.86%	-7.35%	-31.17%	-45.70%	Upgrade
FCF Yield	-28.08%	-21.76%	-6.83%	-5.42%	-27.60%	-116.22%	Upgrade
Buyback Yield / Dilution	-14.42%	-8.23%	-11.73%	-52.86%	-243.98%	-45.87%	Upgrade
Total Shareholder Return	-14.42%	-8.23%	-11.73%	-52.86%	-243.98%	-45.87%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).